News | November 01, 2023
Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The initiative will focus on advocating for cleaner air
With the establishment of five different precious metals alloy powder production methods
RHTC will address a long-standing healthcare access issue for all the local population
Approval based on DESTINY-Lung02 results where AstraZeneca and Daiichi Sankyo’s Enhertu demonstrated a confirmed objective response rate of 49% and median duration of response of 16.8 months in previously treated patients
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Subscribe To Our Newsletter & Stay Updated
